Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Davidson

Showing results (141-150 of 358) with videos related to

Pageof 36
Sort By:
Virchows Archiv : an International Journal of Pathology|October 7, 2006
Expression of E-cadherin transcriptional regulators in ovarian carcinomaSivan Elloul, Ilvars Silins, Claes G Tropé, et al.
Human Pathology|August 23, 2011
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survivalKjersti Brenne, Dag André Nymoen, Thea Eline Hetland, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2017
Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcomaBen Davidson, Ellen Hellesylt, Arild Holth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinomaBen Davidson, Iris Goldberg, Walter H Gotlieb, et al.
Cancers|July 2, 2021
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical RationaleYvonne Andersson, Karianne G Fleten, Torveig W Abrahamsen, et al.
Clinical & Experimental Metastasis|March 10, 2010
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusionsSivan Elloul, Olga Vaksman, Helene Tuft Stavnes, et al.
Plos One|April 9, 2009
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasomeVictoria M Virador, Ben Davidson, Josephine Czechowicz, et al.
BMC Cancer|June 3, 2014
Genomic profile of ovarian carcinomasFrancesca Micci, Lisbeth Haugom, Vera M Abeler, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 6, 2009
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sitesGunhild M Maelandsmo, Vivi Ann Flørenes, Mai T P Nguyen, et al.
American Journal of Clinical Pathology|September 15, 2004
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcomeVivi Ann Flørenes, Gunhild M Maelandsmo, Ruth Holm, et al.
Pageof 36

Showing results (141-150 of 358) with videos related to

Sort By:
Pageof 36
Virchows Archiv : an International Journal of Pathology|October 7, 2006
Expression of E-cadherin transcriptional regulators in ovarian carcinomaSivan Elloul, Ilvars Silins, Claes G Tropé, et al.
Human Pathology|August 23, 2011
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survivalKjersti Brenne, Dag André Nymoen, Thea Eline Hetland, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2017
Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcomaBen Davidson, Ellen Hellesylt, Arild Holth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinomaBen Davidson, Iris Goldberg, Walter H Gotlieb, et al.
Cancers|July 2, 2021
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical RationaleYvonne Andersson, Karianne G Fleten, Torveig W Abrahamsen, et al.
Clinical & Experimental Metastasis|March 10, 2010
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusionsSivan Elloul, Olga Vaksman, Helene Tuft Stavnes, et al.
Plos One|April 9, 2009
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasomeVictoria M Virador, Ben Davidson, Josephine Czechowicz, et al.
BMC Cancer|June 3, 2014
Genomic profile of ovarian carcinomasFrancesca Micci, Lisbeth Haugom, Vera M Abeler, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 6, 2009
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sitesGunhild M Maelandsmo, Vivi Ann Flørenes, Mai T P Nguyen, et al.
American Journal of Clinical Pathology|September 15, 2004
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcomeVivi Ann Flørenes, Gunhild M Maelandsmo, Ruth Holm, et al.
Pageof 36